Safety of treatment with biologics for psoriasis in daily practice: 5-year data
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Safety of treatment with biologics for psoriasis in daily practice: 5-year data ; volume:8 ; number:1 ; day:25 ; month:11 ; year:2010 ; pages:1 ; date:11.2010
Journal of translational medicine ; 8, Heft 1 (25.11.2010), 1, 11.2010
- Urheber
-
Van Lümig, PPM
- Beteiligte Personen und Organisationen
-
Driessen, RJB
Berends, MAM
Boezeman, J B.
van de Kerkhof, PCM
de Jong, EMGJ
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-8-S1-P16
- URN
-
urn:nbn:de:1111-2016041436199
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Van Lümig, PPM
- Driessen, RJB
- Berends, MAM
- Boezeman, J B.
- van de Kerkhof, PCM
- de Jong, EMGJ
- SpringerLink (Online service)
Ähnliche Objekte (12)
Evidenz-basierte Therapie der Psoriasis : Schwerpunkt Biologics
Evidenz-basierte Therapie der Psoriasis : Schwerpunkt Biologics
Autoimmunphänomene in der Therapie der Psoriasis mit Biologics
Evidence-based therapy of Psoriasis: focus on biologics
Biologics als neue Therapieoptionen in der Behandlung der Psoriasis und Psoriasis-Arthritis
Prevalence of antiphospholipid autoantibodies associated with biologics treatment for psoriasis
Residual metabolic burden in young psoriasis patients successfully treated with biologics
Dose Tapering of Biologics in Patients with Psoriasis: A Scoping Review
Pregnancy After Tubal Sterilization in a Woman Treated with Biologics for Severe Psoriasis
Brodalumab to the Rescue: Efficacy and Safety of Brodalumab in Patients with Psoriasis and Prior Exposure or Inadequate Response to Biologics
Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence
Reduced economic disparity in biologics use for psoriasis after introducing the reducing copayment program
Evidenz-basierte Therapie der Psoriasis : Schwerpunkt Biologics
Evidenz-basierte Therapie der Psoriasis : Schwerpunkt Biologics
Autoimmunphänomene in der Therapie der Psoriasis mit Biologics
Evidence-based therapy of Psoriasis: focus on biologics
Biologics als neue Therapieoptionen in der Behandlung der Psoriasis und Psoriasis-Arthritis
Prevalence of antiphospholipid autoantibodies associated with biologics treatment for psoriasis
Residual metabolic burden in young psoriasis patients successfully treated with biologics
Dose Tapering of Biologics in Patients with Psoriasis: A Scoping Review
Pregnancy After Tubal Sterilization in a Woman Treated with Biologics for Severe Psoriasis
Brodalumab to the Rescue: Efficacy and Safety of Brodalumab in Patients with Psoriasis and Prior Exposure or Inadequate Response to Biologics
Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence
Reduced economic disparity in biologics use for psoriasis after introducing the reducing copayment program
Evidenz-basierte Therapie der Psoriasis : Schwerpunkt Biologics
Evidenz-basierte Therapie der Psoriasis : Schwerpunkt Biologics
Autoimmunphänomene in der Therapie der Psoriasis mit Biologics
Evidence-based therapy of Psoriasis: focus on biologics
Biologics als neue Therapieoptionen in der Behandlung der Psoriasis und Psoriasis-Arthritis
Prevalence of antiphospholipid autoantibodies associated with biologics treatment for psoriasis
Residual metabolic burden in young psoriasis patients successfully treated with biologics
Dose Tapering of Biologics in Patients with Psoriasis: A Scoping Review
Pregnancy After Tubal Sterilization in a Woman Treated with Biologics for Severe Psoriasis
Brodalumab to the Rescue: Efficacy and Safety of Brodalumab in Patients with Psoriasis and Prior Exposure or Inadequate Response to Biologics
Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence